Afuco™ Anti-Human IGLL1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IGLL1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibody having immunoreactivity to a polypeptide comprising not less than 7 continuous amino acids in the CD179b protein, which was identified as a cancer antigen protein specifically expressed on the surfaces of cancer cells, can be used as a pharmaceutical composition for therapy and/or prophylaxis of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-373CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IGLL1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |